Posts Feed
Comments Feed

DSMB Again Supports Continuation Of Alimera Sciences’ Phase 3 Clinical Trial Of Iluvien(TM) For The Treatment Of DME

Alimera Sciences, Inc.

More: continued here

No Comments »

Trackback URI | Comments RSS

Leave a Reply

You must be logged in to post a comment.

1